Virtu Financial LLC Novo Cure LTD Transaction History

Virtu Financial LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$67.99 - $89.57 $427,249 - $562,857	6,284 New	6,284 $477,000
Q2 2022 Aug 09, 2022	SELL	$56.6 - $89.9 $248,983 - $395,470	-4,399 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$60.15 - $84.52 $24,601 - $34,568	-409 Reduced 8.51%	4,399 $364,000
Q4 2021 Feb 17, 2022	BUY	$75.08 - $121.99 $360,984 - $586,527	4,808 New	4,808 $361,000
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $679,129 - $1.14 Million	-5,846 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$130.4 - $225.58 $332,128 - $574,552	2,547 Added 77.21%	5,846 $1.3 Million
Q1 2021 May 19, 2021	BUY	$124.11 - $190.17 $409,438 - $627,370	3,299 New	3,299 $436,000
Q4 2020 Feb 24, 2021	SELL	$112.16 - $174.14 $562,258 - $872,963	-5,013 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$58.05 - $111.31 $291,004 - $557,997	5,013 New	5,013 $558,000
Q3 2019 Nov 20, 2019	SELL	$61.86 - $97.8 $1.25 Million - $1.98 Million	-20,245 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$42.22 - $63.23 $854,743 - $1.28 Million	20,245 New	20,245 $1.28 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.